BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23797776)

  • 1. Human papillomavirus infections as a marker to predict overall survival in lung adenocarcinoma.
    Wang JL; Fang CL; Wang M; Yu MC; Bai KJ; Lu PC; Liu HE
    Int J Cancer; 2014 Jan; 134(1):65-71. PubMed ID: 23797776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus infection as a prognostic marker for lung adenocarcinoma: a systematic review and meta-analysis.
    Guo L; Liu S; Zhang S; Chen Q; Zhang M; Quan P; Sun X
    Oncotarget; 2017 May; 8(21):34507-34515. PubMed ID: 28427144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival Rates for Patients With Barrett High-grade Dysplasia and Esophageal Adenocarcinoma With or Without Human Papillomavirus Infection.
    Rajendra S; Xuan W; Merrett N; Sharma P; Sharma P; Pavey D; Yang T; Santos LD; Sharaiha O; Pande G; Cosman P; Wu X; Wang B
    JAMA Netw Open; 2018 Aug; 1(4):e181054. PubMed ID: 30646096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of human papilloma virus (HPV) genotyping and HPV-16 subtyping in vaginal carcinoma.
    Larsson GL; Helenius G; Andersson S; Sorbe B; Karlsson MG
    Gynecol Oncol; 2013 May; 129(2):406-11. PubMed ID: 23402906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of TIMP-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in HPV-infected non-small cell lung cancer.
    Wu DW; Tsai LH; Chen PM; Lee MC; Wang L; Chen CY; Cheng YW; Lee H
    Am J Pathol; 2012 Nov; 181(5):1796-806. PubMed ID: 22982189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of tumor PD-L1 expression with EGFR wild-type status and poor prognosis in lung adenocarcinoma.
    Inamura K; Yokouchi Y; Sakakibara R; Kobayashi M; Subat S; Ninomiya H; Nagano H; Nomura K; Okumura S; Ishikawa Y
    Jpn J Clin Oncol; 2016 Oct; 46(10):935-941. PubMed ID: 27511990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between expression of human papillomavirus 16/18 E6 oncoprotein and survival in patients with stage I non-small cell lung cancer.
    Hsu NY; Cheng YW; Chan IP; Ho HC; Chen CY; Hsu CP; Lin MH; Chou MC
    Oncol Rep; 2009 Jan; 21(1):81-7. PubMed ID: 19082446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women.
    Cheng YW; Chiou HL; Sheu GT; Hsieh LL; Chen JT; Chen CY; Su JM; Lee H
    Cancer Res; 2001 Apr; 61(7):2799-803. PubMed ID: 11306446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
    Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
    J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of human papillomavirus genotypes in bronchial cancer using sensitive multimetrix assay.
    Syrjänen K; Silvoniemi M; Salminen E; Vasankari T; Syrjänen S
    Anticancer Res; 2012 Feb; 32(2):625-31. PubMed ID: 22287755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is human papillomavirus associated with prostate cancer survival?
    Pascale M; Pracella D; Barbazza R; Marongiu B; Roggero E; Bonin S; Stanta G
    Dis Markers; 2013; 35(6):607-13. PubMed ID: 24288430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
    Schwartz SM; Daling JR; Shera KA; Madeleine MM; McKnight B; Galloway DA; Porter PL; McDougall JK
    J Clin Oncol; 2001 Apr; 19(7):1906-15. PubMed ID: 11283122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of human papillomavirus infection on the survival and treatment response of patients with esophageal cancers.
    Wang WL; Wang YC; Lee CT; Chang CY; Lo JL; Kuo YH; Hsu YC; Mo LR
    J Dig Dis; 2015 May; 16(5):256-63. PubMed ID: 25708698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR mutations and human papillomavirus in lung cancer.
    Kato T; Koriyama C; Khan N; Samukawa T; Yanagi M; Hamada T; Yokomakura N; Otsuka T; Inoue H; Sato M; Natsugoe S; Akiba S
    Lung Cancer; 2012 Nov; 78(2):144-7. PubMed ID: 22975156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent prognostic role of human papillomavirus genotype in cervical cancer.
    Hang D; Jia M; Ma H; Zhou J; Feng X; Lyu Z; Yin J; Cui H; Yin Y; Jin G; Hu Z; Shen H; Zhang K; Li N; Dai M
    BMC Infect Dis; 2017 Jun; 17(1):391. PubMed ID: 28583086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus 16/18 infections in lung cancer patients in Mexico.
    Badillo-Almaraz I; Zapata-Benavides P; Saavedra-Alonso S; Zamora-Avila D; Reséndez-Pérez D; Tamez-Guerra R; Herrera-Esparza R; Rodríguez-Padilla C
    Intervirology; 2013; 56(5):310-5. PubMed ID: 23942143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC).
    Stolnicu S; Hoang L; Chiu D; Hanko-Bauer O; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Soslow RA
    Am J Surg Pathol; 2019 Apr; 43(4):466-474. PubMed ID: 30720532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations.
    Kim MH; Kim HR; Cho BC; Bae MK; Kim EY; Lee CY; Lee JS; Kang DR; Kim JH
    Lung Cancer; 2014 May; 84(2):196-202. PubMed ID: 24629638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of cyclooxygenase-2 levels can predict EGFR mutations and the efficacy of EGFR-TKI in patients with lung adenocarcinoma.
    Li H; Wang Y; Su F; Li J; Gong P
    Int J Clin Exp Pathol; 2015; 8(5):5577-83. PubMed ID: 26191267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.